Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Black Diamond Therapeutics (BDTX) Return on Capital Employed: 2020-2021

Historic Return on Capital Employed for Black Diamond Therapeutics (BDTX) over the last 1 years, with Sep 2021 value amounting to -0.42%.

  • Black Diamond Therapeutics' Return on Capital Employed fell 25.00% to -0.42% in Q3 2021 from the same period last year, while for Sep 2021 it was -0.42%, marking a year-over-year decrease of 25.00%. This contributed to the annual value of -0.30% for FY2020, which is 1.00% down from last year.
  • Black Diamond Therapeutics' Return on Capital Employed amounted to -0.42% in Q3 2021, which was down 34.13% from -0.32% recorded in Q2 2021.
  • Black Diamond Therapeutics' Return on Capital Employed's 5-year high stood at -0.13% during Q2 2020, with a 5-year trough of -0.42% in Q3 2021.
  • Its 2-year average for Return on Capital Employed is -0.23%, with a median of -0.19% in 2020.
  • Data for Black Diamond Therapeutics' Return on Capital Employed shows a maximum YoY declined of 25bps (in 2021) over the last 5 years.
  • Black Diamond Therapeutics' Return on Capital Employed (Quarterly) stood at -0.21% in 2020, then fell by 25bps to -0.42% in 2021.
  • Its last three reported values are -0.42% in Q3 2021, -0.32% for Q2 2021, and -0.21% during Q4 2020.